As of 19 Nov 2026, Traitomic has raised $22.0M across 1 verified round on record (amounts in other currencies converted to USD); latest: €20M Series A led by Sofinnova Partners, announced 17 Nov 2026.
A biotechnology company developing non-GE/non-GM traits in plants and microorganisms
traitomic.comCopenhagen, DenmarkBiotech30 people
14 sources · checked 3 times, last 1d ago
Only one source is provided; no source disagreement is present.
| Round | Amount | Announced | Lead | Buzz |
|---|---|---|---|---|
| Series A | $22.0M €20M | 2026-11-17 | Sofinnova Partners | 11 outlets. #87 in Trending |
14 sources · checked 3 times, last 1d ago [ VERIFIED ] read against 1 of 14 sources
Only one source is provided; no source disagreement is present. | ||||
Traitomic develops precise, non-GE/non-GM traits in plants and microorganisms for companies in agriculture, food and biosolutions.
Traitomic says its FIND-IT platform identifies targeted genetic changes in conventional breeding populations and hands over biological material and genetic information for commercialisation, addressing demand for better quality, resilience and efficiency in agriculture, food and industrial biotechnology without GE/GM. Its €20 million Series A—the first external funding since the Carlsberg spinout—will support international expansion and scientific and commercial capabilities, while the company reports 116 traits delivered to 47 customers across 32 organisms and about 100 more in pre-commercial assessment.
Checked against 10 sources 2d ago